Credit Suisse’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $7.91M | Sell |
182,509
-7,213
| -4% | -$313K | 0.01% | 1034 |
|
|
2023
Q4 | $9.6M | Sell |
189,722
-40,621
| -18% | -$2.06M | 0.01% | 941 |
|
|
2023
Q3 | $10.4M | Sell |
230,343
-14,639
| -6% | -$664K | 0.01% | 879 |
|
|
2023
Q2 | $10.1M | Buy |
244,982
+2,911
| +1% | +$119K | 0.01% | 917 |
|
|
2023
Q1 | $8.65M | Buy |
242,071
+57,769
| +31% | +$2.06M | 0.01% | 983 |
|
|
2022
Q4 | $6.96M | Buy |
184,302
+29,604
| +19% | +$1.12M | 0.01% | 1093 |
|
|
2022
Q3 | $6.84M | Buy |
154,698
+4,977
| +3% | +$220K | 0.01% | 1079 |
|
|
2022
Q2 | $5.54M | Sell |
149,721
-30,905
| -17% | -$1.14M | 0.01% | 1205 |
|
|
2022
Q1 | $6.69M | Buy |
180,626
+3,859
| +2% | +$143K | 0.01% | 1260 |
|
|
2021
Q4 | $5.38M | Sell |
176,767
-5,895
| -3% | -$179K | ﹤0.01% | 1450 |
|
|
2021
Q3 | $6.13M | Buy |
182,662
+23,477
| +15% | +$787K | ﹤0.01% | 1405 |
|
|
2021
Q2 | $6.35M | Buy |
159,185
+26,191
| +20% | +$1.04M | ﹤0.01% | 1406 |
|
|
2021
Q1 | $5.98M | Sell |
132,994
-11,894
| -8% | -$535K | ﹤0.01% | 1432 |
|
|
2020
Q4 | $8.19M | Sell |
144,888
-23,155
| -14% | -$1.31M | ﹤0.01% | 1228 |
|
|
2020
Q3 | $7.97M | Sell |
168,043
-8,044
| -5% | -$382K | ﹤0.01% | 1090 |
|
|
2020
Q2 | $10.4M | Buy |
176,087
+41,456
| +31% | +$2.44M | 0.01% | 973 |
|
|
2020
Q1 | $6.37M | Buy |
134,631
+8,198
| +6% | +$388K | 0.01% | 1093 |
|
|
2019
Q4 | $7.64M | Buy |
126,433
+19,558
| +18% | +$1.18M | 0.01% | 1177 |
|
|
2019
Q3 | $6.4M | Sell |
106,875
-164,922
| -61% | -$9.88M | 0.01% | 1194 |
|
|
2019
Q2 | $17.5M | Sell |
271,797
-77,522
| -22% | -$4.98M | 0.02% | 753 |
|
|
2019
Q1 | $28.4M | Sell |
349,319
-157,559
| -31% | -$12.8M | 0.03% | 519 |
|
|
2018
Q4 | $27.4M | Sell |
506,878
-49,618
| -9% | -$2.68M | 0.03% | 506 |
|
|
2018
Q3 | $28.7M | Buy |
556,496
+9,430
| +2% | +$486K | 0.03% | 575 |
|
|
2018
Q2 | $22.8M | Sell |
547,066
-207,745
| -28% | -$8.66M | 0.02% | 646 |
|
|
2018
Q1 | $33.3M | Buy |
754,811
+301,872
| +67% | +$13.3M | 0.03% | 509 |
|
|
2017
Q4 | $22.8M | Buy |
452,939
+138,275
| +44% | +$6.96M | 0.02% | 653 |
|
|
2017
Q3 | $16M | Buy |
314,664
+36,766
| +13% | +$1.86M | 0.02% | 776 |
|
|
2017
Q2 | $14.1M | Sell |
277,898
-107,247
| -28% | -$5.46M | 0.01% | 840 |
|
|
2017
Q1 | $15.5M | Buy |
385,145
+170,192
| +79% | +$6.84M | 0.01% | 831 |
|
|
2016
Q4 | $10.3M | Sell |
214,953
-55,504
| -21% | -$2.66M | 0.01% | 1019 |
|
|
2016
Q3 | $9.91M | Sell |
270,457
-68,587
| -20% | -$2.51M | 0.01% | 1047 |
|
|
2016
Q2 | $7.9M | Sell |
339,044
-38,234
| -10% | -$891K | 0.01% | 1170 |
|
|
2016
Q1 | $15.3M | Buy |
377,278
+36,177
| +11% | +$1.47M | 0.02% | 792 |
|
|
2015
Q4 | $21.1M | Buy |
341,101
+5,061
| +2% | +$313K | 0.02% | 702 |
|
|
2015
Q3 | $13.6M | Sell |
336,040
-469,521
| -58% | -$19M | 0.02% | 880 |
|
|
2015
Q2 | $46.4M | Buy |
805,561
+476,064
| +144% | +$27.4M | 0.05% | 420 |
|
|
2015
Q1 | $21M | Buy |
329,497
+12,247
| +4% | +$780K | 0.02% | 713 |
|
|
2014
Q4 | $19.6M | Buy |
317,250
+5,957
| +2% | +$368K | 0.02% | 771 |
|
|
2014
Q3 | $12.1M | Buy |
311,293
+79,721
| +34% | +$3.1M | 0.01% | 1025 |
|
|
2014
Q2 | $7.98M | Buy |
231,572
+4,310
| +2% | +$148K | 0.01% | 1336 |
|
|
2014
Q1 | $9.82M | Sell |
227,262
-123,954
| -35% | -$5.36M | 0.01% | 1100 |
|
|
2013
Q4 | $14M | Buy |
351,216
+78,177
| +29% | +$3.11M | 0.01% | 883 |
|
|
2013
Q3 | $10.3M | Buy |
273,039
+23,184
| +9% | +$870K | 0.01% | 937 |
|
|
2013
Q2 | $6.71M | Buy |
+249,855
| New | +$6.71M | 0.01% | 1155 |
|